Vivani Medical (VANI) Depreciation & Amortization (CF) (2014 - 2026)

Vivani Medical's Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $130000.0 for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 27.45% year-over-year to $130000.0; the TTM figure through Mar 2026 stood at $452000.0 (up 12.16% YoY), while the FY2025 annual figure was $424000.0, up 6.0% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $130000.0, up from $115000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $130000.0 in Q1 2026, with the low at $71000.0 in Q3 2023.
• The 5-year median for Depreciation & Amortization (CF) is $101000.0 (2022), against an average of $99529.4.
• Peak annual rise in Depreciation & Amortization (CF) reached 357.89% in 2022, while the deepest fall reached 54.71% in 2022.
• Vivani Medical's Depreciation & Amortization (CF) stood at $110000.0 in 2022, then slipped by 10.91% to $98000.0 in 2023, then slipped by 9.18% to $89000.0 in 2024, then advanced by 29.21% to $115000.0 in 2025, then grew by 13.04% to $130000.0 in 2026.
• Business Quant data shows VANI's Depreciation & Amortization (CF) at $130000.0 in Q1 2026, $115000.0 in Q4 2025, and $105000.0 in Q3 2025.